Export

Fluoxetine
Essential medicine status
Section:
24. Medicines for mental and behavioural disorders 24.2. Medicines used in mood disorders 24.2.1. Medicines used in depressive disorders
ATC codes: N06AB03
EMLc
Indication
Depressive disorders ICD11 code: 6A9Z
INN
Fluoxetine
Medicine type
Chemical agent
List type
Core (EML)
Complementary (EMLc)
Additional notes
The square box does not apply to the listing of fluoxetine on the EMLc.
Formulations
Oral > Solid: 20 mg (as hydrochloride)
EML status history
First added in 2007 (TRS 946)
Changed in 2007 (TRS 950)
Changed in 2019 (TRS 1021)
Changed in 2021 (TRS 1035)
Sex
All
Age
Also recommended for children
Age restriction
> 8 years
Therapeutic alternatives
citalopram (ATC codes: N06AB04)
escitalopram (ATC codes: N06AB10)
fluvoxamine (ATC codes: N06AB08)
paroxetine (ATC codes: N06AB05)
sertraline (ATC codes: N06AB06)
Patent information
Patents have expired in most jurisdictions
Wikipedia
Fluoxetine
DrugBank
Fluoxetine
Summary of evidence and Expert Committee recommendations
Following the review of square box listings on the EML and EMLc, the Expert Committee recommended citalopram, escitalopram, fluvoxamine, paroxetine and sertraline be specified as therapeutic alternatives under the square box listing for fluoxetine on the EML. The square box does not apply to the listing of fluoxetine on the EMLc.